• Policy
• Strepto formulations negotiated at a rate of 20%
• by Lee, Tak-Sun Nov 4, 2022 05:39am

• Opinion
• [Reporter’s View] Reimb for SLGT-2i combo still in discussi
• by Eo, Yun-Ho Nov 4, 2022 05:39am

• Policy
• Government-Pharmaceutical Consultation on Acetaminophen
• by Lee, Jeong-Hwan Nov 4, 2022 05:39am

• Policy
• Reimb standards set for first RET-targeted Retevmo
• by Lee, Tak-Sun Nov 4, 2022 05:39am

• Policy
• The self-sufficiency of national essential drugs has begun
• by Lee, Hye-Kyung Nov 4, 2022 05:38am

• Company
• Recobell can be prescribed at infertility centers
• by Eo, Yun-Ho Nov 3, 2022 05:54am

• Downsizing underway at Sanofi... conducts voluntary ERP
• by Nov 3, 2022 05:54am

• Product
• Imported Tylenol is sold at half the domestic price
• by Kim JiEun Nov 3, 2022 05:54am

• Company
• Immuno-oncology drugs set out to conquer early stage cancer
• by Nov 3, 2022 05:54am

• Policy
• Akynzeo is licensed domestically
• by Kim, Jung-Ju Nov 3, 2022 05:54am